Management goals for Gaucher disease type 1, related to general disease management

Category	Management goals
Long-term complications	Early detection of hematologic malignancies, including multiple myeloma, lymphoma, and amyloidosis
	Early detection of solid tumors, including hepatocellular carcinoma and renal cell carcinoma
	Early detection of parkinsonism/Parkinson disease
	Early detection of insulin resistance and type 2 diabetes mellitus
General	Proper education of the patient and his/her family about the disease and therapy
General	Early detection of signs and symptoms indicative of GD3, such as eye movement abnormalities

In addition to these management goals, it is important to detect and treat conditions that are associated with but not specific for GD1, such as iron deficiency anemia, low serum vitamin D concentrations, or cholelithiasis/cholecystitis. Since this is considered good clinical practice rather than management goals for GD, they are not included in this table.

GD3: Gaucher disease type 3; GD1: Gaucher disease type 1.

From: Biegstraaten M, Cox TM, Belmatoug N, et al. Management goals for type 1 Gaucher disease: An expert consensus document for the European working group on Gaucher disease. Blood Cells Mol Dis 2018; 68:203. Copyright © 2018 Elsevier, Inc. Available at: https://www.sciencedirect.com/science/article/pii/S1079979616301917?via%3Dihub (Accessed November 20, 2017). Reproduced under the terms of the Creative Commons Attribution License.

Graphic 115670 Version 1.0

خرید پکیج

Management goals for Gaucher disease type 1, related to general disease management